Katsuhito Hashidzume
President bei HUMAN METABOLOME TECHNOLOGIES, INC.
Vermögen: 30 485 $ am 31.03.2024
Profil
Katsuhito Hashidzume currently works at Human Metabolome Technologies, Inc., as President & Representative Director from 2019, HMT Biomedical KK, as President & Representative Director from 2018, and Mediome KK, as Non-Executive Director from 2018.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
30.06.2023 | 7 044 ( 0,12% ) | 30 485 $ | 31.03.2024 |
Aktive Positionen von Katsuhito Hashidzume
Unternehmen | Position | Beginn |
---|---|---|
HUMAN METABOLOME TECHNOLOGIES, INC. | President | 21.09.2019 |
HMT Biomedical KK
HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | President | 01.12.2018 |
Mediome KK | Director/Board Member | 01.12.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HUMAN METABOLOME TECHNOLOGIES, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
HMT Biomedical KK
HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | Health Technology |
Mediome KK |